Needham & Company LLC Reiterates Buy Rating for Evolent Health (NYSE:EVH)
Needham & Company LLC reaffirmed their buy rating on shares of Evolent Health (NYSE:EVH – Free Report) in a research note published on Friday morning,Benzinga reports. The brokerage currently has a $15.00 target price on the technology company’s stock. Several other research firms have also recently issued reports on EVH. JPMorgan Chase & Co. decreased […]
Needham & Company LLC reaffirmed their buy rating on shares of Evolent Health (NYSE:EVH – Free Report) in a research note published on Friday morning,Benzinga reports. The brokerage currently has a $15.00 target price on the technology company’s stock. Several other research firms have also recently issued reports on EVH. JPMorgan Chase & Co. decreased […]
